{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03886",
      "entity_text" : "H1299L858R",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:123631",
      "entity_text" : "gefitinib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In addition, H1299L858R, which is supposed to be more sensitive to gefitinib than H1299EGFR-WT, was effectively inhibited by gefitinib administration at the downstream part of the signaling pathway (MEK and ERK) compared with H1299EGFR-WT, but, surprisingly, not at the upstream part of the pathway (EGFR and Shc).",
  "reading_complete" : "2020-08-03T16:19:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:16:02Z",
  "trigger" : "inhibited",
  "evidence" : [ "H1299L858R, which is supposed to be more sensitive to gefitinib than H1299EGFR-WT, was effectively inhibited by gefitinib" ],
  "pmc_id" : "3224393",
  "score" : 0
}